Translating basic, preclinical research into safe, effective application in the treatment of patients is a matter of increasing emphasis by all sponsors--commercial or Federal.  This was articulated as a specific administrative and policy agenda by the leadership of the NIH (see NIH Translational Research Agenda).   All sectors of the drug/device development industry are affected by the renewed commitment to translational research: Academic and Community-based Medical Centers; Sponsors--Pharma/Biotech/Engineered Products/Devices/Federal; Regulatory Agencies; Compliance Oversight and Consulting Firms; Trade Organizations;  Information Technology Firms; Financial/Investment Organizations.   For information specific to each of these sectors, please refer to the dedicated links above. 

Copyright: 2005